Comparison of Efficacy of Ferric Carboxymaltose versus Iron Sucrose Complex for the Treatment of Iron Deficiency Anemia in Pregnancy: Ferric Carboxymaltose versus Iron Sucrose Complex for Iron Deficiency Anemia in Pregnancy

Florentina Prastish Javed; Sumaira Kanwal; Ayesha Azhar Khan; Asma Amin Baig; Muhammad Rabeet; Muhammad Owais Qurshi; Hafiz Muhammad Zeeshan Raza; Muhammad Imran Arif

doi:10.54393/pjhs.v7i2.3577

Authors

Florentina Prastish Javed Department of Gynaecology and Obstetrics, Rashid Latif Medical College, Arif Memorial Teaching Hospital, Lahore, Pakistan
Sumaira Kanwal Department of Gynaecology and Obstetrics, Rashid Latif Medical College, Arif Memorial Teaching Hospital, Lahore, Pakistan
Ayesha Azhar Khan Department of Gynaecology and Obstetrics, Rashid Latif Medical College, Arif Memorial Teaching Hospital, Lahore, Pakistan
Asma Amin Baig Department of Gynaecology and Obstetrics, Rashid Latif Medical College, Arif Memorial Teaching Hospital, Lahore, Pakistan
Muhammad Rabeet Department of Gynaecology and Obstetrics, Rashid Latif Medical College, Arif Memorial Teaching Hospital, Lahore, Pakistan
Muhammad Owais Qurshi Department of Medicine, Lahore General Hospital, Lahore, Pakistan
Hafiz Muhammad Zeeshan Raza Department of Medicine, The University of Lahore Teaching Hospital, Lahore, Pakistan
Muhammad Imran Arif Xinjiang Medical University, Urumqi, China

DOI:

https://doi.org/10.54393/pjhs.v7i2.3577

Keywords:

Iron Deficiency Anemia, Pregnancy, Ferric Carboxymaltose, Iron Sucrose, Intravenous Iron, Hemoglobin, Parity, Adverse Effects, Maternal Health

Abstract

During pregnancy, iron deficiency anemia (IDA) is a common complication that exposes both the mother and fetus to a lot of risks. Objectives: To compare intravenous ferric carboxymaltose (FCM) versus iron sucrose in the treatment of moderate to severe anemia in pregnant women. Methods: This quasi-experimental study was conducted in a tertiary care hospital in Lahore, which registered 62 pregnant women having 16-34 weeks of gestation and hemoglobin levels of 7-9 g/dl. The participants were randomly divided into two groups, with intravenous FCM in one of them and the other without. The level of base hemoglobin and post-treatment were taken three weeks after the completion. There was also the evaluation of effectiveness and adverse impacts. Results: The average basal hemoglobin was 7.88 ± 0.42 g/dl. The levels after treatment were significantly higher in the FCM group (10.93 ± 0.63 g/dl) compared to the IS group (9.98 ± 0.51 g/dl), with an increase in statistically significant HB (p<0.001). The efficacy was reported in 87.1% of patients treated with FCM versus 38.7% in the SI group. The adverse effects were remarkably lower in the FCM group (19.4%) compared to IS (61.3%) (p=0.001). Although multiparous women had significantly lower basal HB, both parity groups showed similar responses to treatment. Conclusions: Ferric carboxymaltose demonstrated superior efficacy and tolerability compared to iron sucrose in the first leg during pregnancy. Its ability to achieve rapid HB correction with fewer side effects supports its consideration as preferred intravenous iron therapy.

References

Obianeli C, Afifi K, Stanworth S, Churchill D. Iron Deficiency Anaemia in Pregnancy: A Narrative Review from a Clinical Perspective. Vol. 14, Diagnostics. 2024. https://doi.org/10.3390/diagnostics14202306 DOI: https://doi.org/10.3390/diagnostics14202306

Jabeen M, Islam F, Azmaeen S. Injectable Ferric Carboxy Maltose Versus Oral Ferrous Fumerrate in Treatment of Iron Deficiency Anaemia in Pregnancy-A Randomized Controlled Trial. Saudi J Med Pharm Sci. 2025;11(8):747–52. https://doi.org/10.36348/sjmps.2025.v11i08.003 DOI: https://doi.org/10.36348/sjmps.2025.v11i08.003

Ruiz de Viñaspre-Hernández R, Juárez-Vela R, Garcia-Erce JA, Nanwani-Nanwani K, González-Fernández S, Gea-Caballero V, et al. Iron deficiency anemia during pregnancy and maternal and neonatal health outcomes: A prospective study, Spain, 2021–2022. Heliyon [Internet]. 2025 Jan 15;11(1). Available from: https://doi.org/10.1016/j.heliyon.2024.e41565 DOI: https://doi.org/10.1016/j.heliyon.2024.e41565

Naz S, Shahid S, Noorani S, Fatima I, Jaffar A, Kashif M, et al. Management of iron deficiency anemia during pregnancy: a midwife-led continuity of care model. Front Nutr. 2024;11:1400174. https://doi.org/10.3389/fnut.2024.1400174 DOI: https://doi.org/10.3389/fnut.2024.1400174

Rahman H, Saikia T, Khalda E. Comparative evaluation of efficacy, safety, cost effectiveness and acceptability of ferric carboxymaltose versus iron sucrose for treatment of iron deficiency anaemia in pregnancy: A multicenter open label randomized controlled trial. 2023 doi:10.26655/JMCHEMSCI.2023.2.3 DOI: https://doi.org/10.26655/JMCHEMSCI.2023.2.3

Sattar S, Sultana S, Shadab W, Afzal S, Salma U e, Mobeen A. Comparison of Safety and Efficacy of Ferric Carboxymaltose with Iron Sucrose for the Treatment of Iron Deficiency Anemia in Pregnancy. In: Medical Forum Monthly. 2023.

Arzoo K, Jan S, Anwar R, Ali R, Masood A, Rehman MAU. Efficacy of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in the Treatment of Iron Deficiency Anemia of Pregnancy: Intravenous Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia. Pakistan J Heal Sci. 2025;131–5. https://doi.org/10.54393/pjhs.v6i2.2328 DOI: https://doi.org/10.54393/pjhs.v6i2.2328

Papaniya TD, Parmar MT, Solanki HM. Comparison of ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia in pregnancy at tertiary care centre, Western India. Int J Reprod Contraception, Obstet Gynecol. 2023;12(6):1845. https://doi.org/10.18203/2320-1770.ijrcog20231566 DOI: https://doi.org/10.18203/2320-1770.ijrcog20231566

Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy-randomised controlled trial. BMC Pregnancy Childbirth. 2019;19(1):1–8. https://doi.org/10.1186/s12884-019-2200-3 DOI: https://doi.org/10.1186/s12884-019-2200-3

Srimathi G, Revathy R, Bagepally BS, Joshi B. Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis. Indian J Med Res. 2024;159(1):62–70. https://doi.org/10.4103/ijmr.ijmr_246_23 DOI: https://doi.org/10.4103/ijmr.ijmr_246_23

Shin HW, Go DY, Lee SW, Choi YJ, Ko EJ, You HS, et al. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(20):e24571. https://doi.org/10.1097/md.0000000000024571 DOI: https://doi.org/10.1097/MD.0000000000024571

Patel GR, Thanvi I, Seervi RC, Jakhar R. Evaluation of therapeutic response and tolerability to intravenous iron sucrose and ferric carboxymaltose among pregnant women with iron? deficiency anemia: A 6? year experience in a tertiary care center. Med Int. 2025;5(4):34. https://doi.org/10.3892/mi.2025.233 DOI: https://doi.org/10.3892/mi.2025.233

Khan FH, Khalid AA, Alkwai HM, Alshammari RF, Alenazi F, Alshammari KF, et al. The Effect of High Parity on the Occurrence of Anaemia in Pregnant Women. J Coll Physicians Surg JCPSP. 2023;33(12):1400–4. https://doi.org/10.29271/jcpsp.2023.12.1400 DOI: https://doi.org/10.29271/jcpsp.2023.12.1400

Alwan NA, Cade JE, McArdle HJ, Greenwood DC, Hayes HE, Simpson NAB. Maternal iron status in early pregnancy and birth outcomes: insights from the Baby’s Vascular health and Iron in Pregnancy study. Br J Nutr. 2015;113(12):1985–92. https://doi.org/10.1017/s0007114515001166 DOI: https://doi.org/10.1017/S0007114515001166

Saleem K, Yaseen N, Saleem H, Noor L, Arif M, Nawaz MM. Comparison of Ferric Carboxymaltose Versus Iron Sucrose for Treatment of Iron Deficiency Anaemia in Pregnant Women. J Soc Obstet Gynaecol Pakistan. 2025;15(3):155–60. https://doi.org/10.71104/jsogp.v15i3.896 DOI: https://doi.org/10.71104/jsogp.v15i3.896

Gupte S, Mukhopadhyay A, Puri M, Gopinath PM, Wani R, Sharma JB, et al. A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy. Rev Bras Ginecol e Obs. 2024;46:e-rbgo21. https://doi.org/10.61622/rbgo/2024ao21 DOI: https://doi.org/10.61622/rbgo/2024AO21

Bharadwaj MK, Patrikar S, Singh Y. Comparative analysis of injection ferric carboxymaltose vs iron sucrose for treatment of iron-deficiency anemia in pregnancy: systematic review and meta-analysis. J South Asian Fed Obstet Gynaecol. 2023;15(5):629–36. doi: 10.5005/jp-journals-10006-2311 DOI: https://doi.org/10.5005/jp-journals-10006-2311

Lusingu JPA, Maisonet E. Ferric carboxymaltose: a potential game changer. Lancet Glob Heal. 2024;12(12):e1921–2. https://doi.org/10.1016/s2214-109x(24)00455-8 DOI: https://doi.org/10.1016/S2214-109X(24)00455-8

Singh S, Agarwal R, Sharma M, Singh N, Tyagi A. A Comparative Study between Efficacy of Ferric Carboxymaltose and Iron Sucrose Complex for Treatment of Iron Deficiency Anemia in Pregnancy. J South Asian Fed Obstet Gynaecol. 2024;16(4):369–72.doi: 10.5005/jp-journals-10006-2448 DOI: https://doi.org/10.5005/jp-journals-10006-2448

Basha A, Ibrahim MIM, Hamad A, Chandra P, Omar NE, Abdullah MAJ, et al. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia. PLoS One. 2021;16(8):e0255104. https://doi.org/10.1371/journal.pone.0255104 DOI: https://doi.org/10.1371/journal.pone.0255104

Ram K, Arya K, Hooja N, Singh N, Jaiswal A. Comparison of efficacy of injection ferric carboxymaltose and iron sucrose in moderate anaemia in pregnancy. Int J Reprod Contracept Obs Gynecol. 2021;10(7):2794–8. https://doi.org/10.18203/2320-1770.ijrcog20212670 DOI: https://doi.org/10.18203/2320-1770.ijrcog20212670

Hejazi A, Mohamed O, Alhowimel M, AlAdham M. Ferric Carboxymaltose Solution Versus Iron Sucrose Complex in Treating Iron-Deficiency Anemia Patients with Heavy Uterine Bleeding: A Cost-Efficacy Study from a Tertiary Care Hospital in the Kingdom of Saudi Arabia. J Appl Hematol. 2021;12(1):17–21. https://doi.org/10.4103/joah.joah_134_20 DOI: https://doi.org/10.4103/joah.joah_134_20

Saini N, Sharma A. Iron Sucrose vs Iron Ferric Carboxymaltose-Which is better in Anemia in Pregnancy. South Asian Res J Med Sci. 2022;4(2):37–41. https://doi.org/10.36346/sarjms.2022.v04i02.003 DOI: https://doi.org/10.36346/sarjms.2022.v04i02.003

Dakhale GN, Kalikar M V, Fuke RP, Parmarthi AS, Chokhandre MK. Comparative study of efficacy and safety of parenteral iron sucrose versus ferric carboxymaltose in treatment of postpartum iron deficiency anemia. Int J Reprod Contracept Obs Gynecol. 2021;11(100):1770–2320 https://doi.org/10.18203/2320-1770.ijrcog20215083. DOI: https://doi.org/10.18203/2320-1770.ijrcog20215083

Malik A, Janjua M, Shahzad Q, Sattar Y. Comparison of Iron Sucrose Complex Versus Ferric Carboxymaltose for Establishment of Effective Breastfeeding: A Quasi-Experimental Study. J Soc Obstet Gynaecol Pakistan. 2025;15(3):185–90. https://doi.org/10.71104/jsogp.v15i3.936 DOI: https://doi.org/10.71104/jsogp.v15i3.936